EF2_METTE
ID EF2_METTE Reviewed; 730 AA.
AC O93640;
DT 30-MAY-2000, integrated into UniProtKB/Swiss-Prot.
DT 01-MAY-1999, sequence version 1.
DT 03-AUG-2022, entry version 108.
DE RecName: Full=Elongation factor 2;
DE Short=EF-2;
GN Name=fusA; Synonyms=fus;
OS Methanosarcina thermophila.
OC Archaea; Euryarchaeota; Stenosarchaea group; Methanomicrobia;
OC Methanosarcinales; Methanosarcinaceae; Methanosarcina.
OX NCBI_TaxID=2210;
RN [1]
RP NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC STRAIN=ATCC 43570 / DSM 1825 / OCM 12 / TM-1;
RX PubMed=9845338; DOI=10.1016/s0014-5793(98)01375-1;
RA Thomas T., Cavicchioli R.;
RT "Archaeal cold-adapted proteins: structural and evolutionary analysis of
RT the elongation factor 2 proteins from psychrophilic, mesophilic and
RT thermophilic methanogens.";
RL FEBS Lett. 439:281-287(1998).
CC -!- FUNCTION: Catalyzes the GTP-dependent ribosomal translocation step
CC during translation elongation. During this step, the ribosome changes
CC from the pre-translocational (PRE) to the post-translocational (POST)
CC state as the newly formed A-site-bound peptidyl-tRNA and P-site-bound
CC deacylated tRNA move to the P and E sites, respectively. Catalyzes the
CC coordinated movement of the two tRNA molecules, the mRNA and
CC conformational changes in the ribosome (By similarity). {ECO:0000250}.
CC -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}.
CC -!- SIMILARITY: Belongs to the TRAFAC class translation factor GTPase
CC superfamily. Classic translation factor GTPase family. EF-G/EF-2
CC subfamily. {ECO:0000305}.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR EMBL; AF026165; AAC79200.1; -; Genomic_DNA.
DR PIR; T44246; T44246.
DR AlphaFoldDB; O93640; -.
DR SMR; O93640; -.
DR GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR GO; GO:0005525; F:GTP binding; IEA:UniProtKB-UniRule.
DR GO; GO:0003924; F:GTPase activity; IEA:InterPro.
DR GO; GO:0003746; F:translation elongation factor activity; IEA:UniProtKB-UniRule.
DR Gene3D; 3.30.230.10; -; 1.
DR Gene3D; 3.40.50.300; -; 1.
DR HAMAP; MF_00054_A; EF_G_EF_2_A; 1.
DR InterPro; IPR041095; EFG_II.
DR InterPro; IPR035647; EFG_III/V.
DR InterPro; IPR000640; EFG_V-like.
DR InterPro; IPR004161; EFTu-like_2.
DR InterPro; IPR031157; G_TR_CS.
DR InterPro; IPR027417; P-loop_NTPase.
DR InterPro; IPR020568; Ribosomal_S5_D2-typ_fold.
DR InterPro; IPR014721; Ribosomal_S5_D2-typ_fold_subgr.
DR InterPro; IPR005225; Small_GTP-bd_dom.
DR InterPro; IPR000795; T_Tr_GTP-bd_dom.
DR InterPro; IPR009000; Transl_B-barrel_sf.
DR InterPro; IPR004543; Transl_elong_EFG/EF2_arc.
DR InterPro; IPR005517; Transl_elong_EFG/EF2_IV.
DR Pfam; PF00679; EFG_C; 1.
DR Pfam; PF14492; EFG_III; 1.
DR Pfam; PF03764; EFG_IV; 1.
DR Pfam; PF00009; GTP_EFTU; 1.
DR Pfam; PF03144; GTP_EFTU_D2; 1.
DR PRINTS; PR00315; ELONGATNFCT.
DR SMART; SM00838; EFG_C; 1.
DR SMART; SM00889; EFG_IV; 1.
DR SUPFAM; SSF50447; SSF50447; 1.
DR SUPFAM; SSF52540; SSF52540; 1.
DR SUPFAM; SSF54211; SSF54211; 1.
DR SUPFAM; SSF54980; SSF54980; 2.
DR TIGRFAMs; TIGR00490; aEF-2; 1.
DR TIGRFAMs; TIGR00231; small_GTP; 1.
DR PROSITE; PS00301; G_TR_1; 1.
DR PROSITE; PS51722; G_TR_2; 1.
PE 3: Inferred from homology;
KW Cytoplasm; Elongation factor; GTP-binding; Nucleotide-binding;
KW Protein biosynthesis.
FT CHAIN 1..730
FT /note="Elongation factor 2"
FT /id="PRO_0000091036"
FT DOMAIN 19..260
FT /note="tr-type G"
FT BINDING 28..35
FT /ligand="GTP"
FT /ligand_id="ChEBI:CHEBI:37565"
FT /evidence="ECO:0000250"
FT BINDING 94..98
FT /ligand="GTP"
FT /ligand_id="ChEBI:CHEBI:37565"
FT /evidence="ECO:0000250"
FT BINDING 148..151
FT /ligand="GTP"
FT /ligand_id="ChEBI:CHEBI:37565"
FT /evidence="ECO:0000250"
FT MOD_RES 596
FT /note="Diphthamide"
FT /evidence="ECO:0000250"
SQ SEQUENCE 730 AA; 80565 MW; 3D5197BFC2000246 CRC64;
MGRRKKMVER VTTLMNEPEK IRNIGIVAHI DHGKTTLSDN LLAGAGMISK ELAGRQLFMD
SDEEEQERGI TIDASNVSMV HTYNNEDYLI NLIDTPGHVD FGGDVTRAMR AVDGAVVVVD
AVEGTMPQTE TVLRQALREH VRPVLFVNKV DRLINELQVD SQEMQVRLGK VIDHVNKLIK
NMNPEKFKAG WKVDAAAGTV AFGSALYNWA ISVPMMQKTG ISFTNVYDYC KAEDMKALAE
KCPLHATVLD MVIRFLPNPL EAQKGRVPTI WHGDANSEIG KSMASANADG DLAFMVTDIS
IDPHAGEVAT GRLFSGSFSR GMEVYISGTA RKSRVQQVGI FMGPERLEVE KIPAGNIAAV
TGLKDAIVGS TVTTLDGMTP FESIRHVSEP VVTVAVEAKH TKDLPKLVEV LRQVAKEDPT
LQITLDEETG EHLMAGMGEL HLEVIAHRIQ RDKNVEITTS KPIVVYRETI KKKIEPVEGK
SPNRHNRFYI YVEPLDTAIV EMIKSGDISM NLPELERRQK LIELGMGKEE AKGIVGIHNS
NIFIDITKGI QYLNETMELI LDGFEEVMRA GPLTREPVAN MKCVLVDAKL HEDAIHRGPA
QVIPAARQAI QAGMLMAEDC LLEPYQKVFV QVPQLTMGGA TKELQGRRGI ILNMTTEGDL
AIIEARVPVA EMFGFAGEIR SATEGRAMWS TEFGGFDIVP TSIQTEVVGQ IRERKGLKRD
LPKASDYLSM